Authors: Salvatore Paiella Giuseppe Malleo Laura Maggino Claudio Bassi Roberto Salvia Giovanni Butturini
Publish Date: 2015/07/10
Volume: 19, Issue: 9, Pages: 1610-1620
Abstract
Clinical pathologic and followup details were extracted from our database and analyzed retrospectively Survival analysis was performed using univariate and multivariate models We also performed a matched casecontrol analysis with resected patients who did not receive extended lymphadenectomy and with locally advanced patientsThe study population consisted of 67 patients The rate of station 16b1 metastases was 209 Station 14ab metastases OR = 428 G3 tumors OR = 403 and number of PLN ≥ 8 OR = 446 were independently associated with station 16b1 involvement Among pN1 patients station 14ab HR = 260 and station 16b1 metastases HR = 240 were predictors of survival The median diseasespecific survival of 16b1+ patients was 17 months 95 CI 847–2552 In the matched casecontrol analysis the survival rates of resected 16b1+ patients was in between pN1/16b1− patients and locally advanced patients
Keywords: